GlassScriptPhysician profile
Mokhtar Hacena
NPI 1861448110
$385.76
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Allergy & Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $79.33 · 2021: $13.17 · 2022: $24.33 · 2023: $61.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $45.73 | 2019 | |
| Abiomed | $45.46 | 2023 | Impella |
| Otsuka America Pharmaceutical, INC. | $36.25 | 2019-2020 | |
| Novo Nordisk INC | $31.67 | 2019-2020 | |
| Allergan, INC. | $26.72 | 2019-2020 | |
| Lilly USA, LLC | $26.43 | 2019-2022 | |
| Senseonics, Incorporated | $25.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $24.05 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $17.98 | 2019 | |
| Amgen INC. | $16.22 | 2023 | Evenity, Prolia |
| Amarin Pharma, INC. | $15.00 | 2020 | |
| Horizon Therapeutics Plc | $14.67 | 2019 | |
| Melinta Therapeutics, LLC | $13.28 | 2019 | |
| Medtronic Minimed, INC. | $12.88 | 2020 | |
| Medtronic, INC. | $11.87 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $11.50 | 2019 | |
| Merck Sharp & Dohme LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mokhtar Hacena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.